Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389050 | SCV001590255 | pathogenic | not provided | 2020-03-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp20*) in the COL9A1 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in COL9A1 are known to be pathogenic (PMID: 16909383, 21421862). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with COL9A1-related conditions. This variant is not present in population databases (ExAC no frequency). |